| Bioactivity | HIV-1 protease-IN-11 (compound 34a) is a HIV-1 protease inhibitor with an IC50 of 0.41 nM. HIV-1 protease-IN-11 also exhibits significant activity against drug-resistant variant[1]. |
| Name | HIV-1 protease-IN-11 |
| CAS | 2925287-54-1 |
| Formula | C26H37N3O5S |
| Molar Mass | 503.65 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Huiyu Zhou, et al. Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant. Eur J Med Chem. 2023 Jul 5;255:115389. |
HIV-1 protease-IN-11
CAS: 2925287-54-1 F: C26H37N3O5S W: 503.65
HIV-1 protease-IN-11 (compound 34a) is a HIV-1 protease inhibitor with an IC50 of 0.41 nM. HIV-1 protease-IN-11 also exh
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.